Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19

Name: Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19
License: Public Domain

BioXcellerator

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

acute respiratory distress syndrome

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 256947
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.